Compare TransMedics Group Inc (TMDX) vs State Street Real Estate Select Sector SPDR ETF (XLRE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TransMedics Group Inc vs State Street Real Estate Select Sector SPDR ETF — how do they compare? TransMedics Group Inc trades at $89.34 (market cap $3.02B), while State Street Real Estate Select Sector SPDR ETF trades at $45.07. The key difference: State Street Real Estate Select Sector SPDR ETF is trading nearer its 52-week high, TransMedics Group Inc nearer its low. Which is the better fit depends on your goals.
| TMDX | XLRE | |
|---|---|---|
Market Cap | $3.02B | — |
Sector | Technology | Sector/Thematic |
52-Week High | $150.42 | $46.01 |
52-Week Low | $61.99 | $40.01 |
Enterprise Value | $3.41B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
TransMedics Group (TMDX) trades at $87.02, down 2.62% on the day, amid mixed earnings performance. The stock shows strong profitability with a 22.69% net margin and 36.28% ROE, but recent quarters saw misses on EPS expectations. Technicals are bullish with moving averages supporting upside, while oscillators signal caution. Recent news highlights an ongoing legal investigation into fiduciary duties by company directors.
The outlook is cautiously optimistic with a consensus price target of $99.57 implying 14% upside, supported by bullish analyst ratings. Key risks include earnings volatility, rising costs impacting margins, and potential legal overhangs from the fiduciary investigation. Revenue growth remains a positive catalyst, but investors should monitor execution against future guidance.
XLRE trades at $44.48, up 0.91% with a bearish technical signal from moving averages. The ETF shows neutral oscillators with RSI at oversold levels, suggesting potential for near-term stabilization. Recent news highlights real estate ETFs gaining attention as inflation hedges, with XLRE offering low-cost exposure to U.S. REITs at a 0.08% expense ratio. Dividend payments are scheduled for June 2026 at $0.38 per share.
The outlook for XLRE is cautiously optimistic as real estate shows resilience amid inflation pressures. Key opportunities include sector diversification and income generation, while risks center on interest rate sensitivity and economic volatility. Technical indicators suggest near-term consolidation around current price levels with support at $44 and resistance at $45.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →About State Street Real Estate Select Sector SPDR ETF
XLRE tracks the Real Estate Select Sector Index, providing exposure to S&P 500 real estate companies. It focuses on equity REITs across residential, industrial, and healthcare sub-sectors, with top holdings like Welltower, Prologis, and American Tower.
Read more on XLRE →
